<DOC>
	<DOCNO>NCT02616432</DOCNO>
	<brief_summary>A randomized screening trial compare diagnostic accuracy screen breast cancer three-dimensional digital breast tomosynthesis ( DBT ) plus two-dimensional full-field digital mammography ( FFDM ) versus FFDM alone .</brief_summary>
	<brief_title>Tomosynthesis Mammography Imaging Screening Trial</brief_title>
	<detailed_description>The Tomosynthesis Mammography Imaging Screening Trial ( TMIST ) LEAD-IN conducted ensure Eastern Cooperative Oncology Group / American College Radiology Imaging Network ( ECOG/ACRIN ) TMIST component properly functional provide opportunity fine tune launch full TMIST . The accrual target TMIST LEAD-IN 6354 participant ( one tenth project enrollment target TMIST ) three lead-in study site : 1 . Sunnybrook Health Sciences Centre Toronto , 2 . Vancouver ( auspex Screening Mammography Programme British Columbia ) 3 . The Ottawa Hospital .</detailed_description>
	<criteria>Asymptomatic woman age 40 Scheduled screen mammogram Able tolerate digital breast tomosynthesis fullfield digital mammographic imaging require protocol Willing able provide write informed consent . Presenting mammography symptom breast disease Have new breast complaint ( e.g . lump , nipple discharge ) Have mammogram breast within last 11 month Previous personal history breast cancer Has breast enhancement ( e.g . implant injection ) Pregnancy intent become pregnant .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tomosynthesis</keyword>
	<keyword>Digital Breast Tomosynthesis ( DBT )</keyword>
	<keyword>Breast Imaging</keyword>
	<keyword>Full-field digital mammography</keyword>
	<keyword>Breast screen</keyword>
</DOC>